Search for: "Sanofi US Corporation"
Results 61 - 80
of 103
Sorted by Relevance
|
Sort by Date
14 Dec 2007, 1:00 am
: (IAM), (Spicy IP),ItalyThe objective technical opinion of AIPPI Italy: (CATCH US IF YOU CAN!!!) [read post]
28 Mar 2011, 10:51 am
The Cowan firm represents numerous corporations which oppose the FCA, including pharmaceutical companies like Eli Lilly, Merck, and SANOFI-Aventis as well as financial groups like Morgan Stanley and Citigroup. [read post]
30 Jan 2007, 3:35 pm
O'Neill, a vice president of the pharmaceutical company Sanofi-Aventis, said guidance documents sometimes undermined or negated the effects of formal regulations. [read post]
15 Dec 2008, 2:00 pm
Evan Chesler of Cravath, Swaine & Moore argued the appeal for Bristol and Sanofi. [read post]
25 Jan 2009, 2:36 pm
Terms of use agreement and privacy policy. [read post]
14 Apr 2024, 9:05 pm
In Panuwat, the defendant was an employee of Medivation, Inc., a mid-cap oncology firm that was resisting one hostile bidder (Sanofi S.A.) and encouraging another firm (Pfizer) to outbid Sanofi. [read post]
11 Jul 2008, 4:30 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
13 Oct 2011, 7:45 pm
" Ecolab, 569 F.3d at 1352 (quoting Sanofi-Synthelabo v. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
2 Nov 2022, 11:43 am
Sanofi, a case arising from Amgen’s efforts to patent antibodies that lower cholesterol levels. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
23 Aug 2008, 1:23 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
5 Jan 2021, 12:28 pm
The Boston US Attorney’s office has collected nearly a billion dollars pursuing cases with a similar theory against many giants in the industry including Pfizer, United Therapeutics, Amgen, Astellas, Alexion, Actelion, Jazz, and Sanofi-Aventis and is currently pursuing a similar case against Regeneron. [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay… [read post]
11 Jan 2008, 9:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]Highlights this week included: European Commission launches consultation on ‘Content Online in the Single Market': (IPKat), (Out-Law), (IPR Helpdesk), UK government launches consultation on copyright exceptions: (IPKat), (Michael Geist), (IMPACT), (Patry Copyright Blog), (Out-Law), (Ars Technica), (IP Law360), Cordis Corporation - US… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows… [read post]
21 Jan 2024, 9:01 pm
The Merger Guidelines note that analytical or surveillance tools used to track or predict competitor prices or actions, such as pricing algorithms, may increase market observability and, in turn, make a market more susceptible to coordination. [read post]
14 Dec 2010, 8:31 am
Some of the more notable ones included BHP Billiton/Potash, Sanofi-Aventis/Genzyme, Airgas/Air Products, Alimentation Couche-Tard/Casey’s and Astellas/OSI. [read post]
23 Jan 2024, 9:01 pm
Cardinal Health The $109 million settlement with Cardinal Health resolves allegations concerning the acquisition and integration of Cordis Corporation from Johnson & Johnson for $1.9 billion in 2015. [read post]
19 Jul 2022, 2:59 pm
Finally, we describe and analyze the real driving forces behind these decisions, and we explain how biotech companies, their attorneys, and insurers can use these insights to greatest advantage. [read post]
